Bridget E. Bunner

Array ( [id] => 5638084 [patent_doc_number] => 20060069058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Beta-sheet breaker peptide analogs that inhibit beta-pleated sheet formation in amyloid beta-peptide' [patent_app_type] => utility [patent_app_number] => 11/271021 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7680 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069058.pdf [firstpage_image] =>[orig_patent_app_number] => 11271021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569345 [patent_doc_number] => 20090252723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Remedy for endometriosis' [patent_app_type] => utility [patent_app_number] => 11/666695 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14403 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252723.pdf [firstpage_image] =>[orig_patent_app_number] => 11666695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880499 [patent_doc_number] => 20060029581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells' [patent_app_type] => utility [patent_app_number] => 11/237876 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15843 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029581.pdf [firstpage_image] =>[orig_patent_app_number] => 11237876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880922 [patent_doc_number] => 20060030005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'C3b/C4b complement receptor-like molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/235732 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 29265 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030005.pdf [firstpage_image] =>[orig_patent_app_number] => 11235732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5526801 [patent_doc_number] => 20090196878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'Intestinal epithelial glucose sensor' [patent_app_type] => utility [patent_app_number] => 11/663540 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5090 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20090196878.pdf [firstpage_image] =>[orig_patent_app_number] => 11663540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 169830 [patent_doc_number] => 07662392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Use of SDF-1 or G-CSF to improve myocardial function after ischemic injury' [patent_app_type] => utility [patent_app_number] => 11/234879 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 53 [patent_no_of_words] => 17258 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662392.pdf [firstpage_image] =>[orig_patent_app_number] => 11234879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786918 [patent_doc_number] => 20060205823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Treatment of allergic diseases using a modulator of the Notch signaling pathway' [patent_app_type] => utility [patent_app_number] => 11/231494 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 46883 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205823.pdf [firstpage_image] =>[orig_patent_app_number] => 11231494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666661 [patent_doc_number] => 20060172011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Medical treatment' [patent_app_type] => utility [patent_app_number] => 11/232404 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 63234 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172011.pdf [firstpage_image] =>[orig_patent_app_number] => 11232404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5826976 [patent_doc_number] => 20060062788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Method for determining MIF content' [patent_app_type] => utility [patent_app_number] => 11/225124 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 31293 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062788.pdf [firstpage_image] =>[orig_patent_app_number] => 11225124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045556 [patent_doc_number] => 20070264229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Peptides for Treatment of Autoimmune Disease' [patent_app_type] => utility [patent_app_number] => 11/662697 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15881 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264229.pdf [firstpage_image] =>[orig_patent_app_number] => 11662697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 557233 [patent_doc_number] => 07468422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-23 [patent_title] => 'Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids' [patent_app_type] => utility [patent_app_number] => 11/224260 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 32 [patent_no_of_words] => 5606 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/468/07468422.pdf [firstpage_image] =>[orig_patent_app_number] => 11224260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870727 [patent_doc_number] => 08466104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Therapeutically active alpha MSH analogues' [patent_app_type] => utility [patent_app_number] => 12/064923 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25612 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12064923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297055 [patent_doc_number] => 20090011981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Novel Inhibitors of Angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/662994 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13189 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20090011981.pdf [firstpage_image] =>[orig_patent_app_number] => 11662994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977864 [patent_doc_number] => 20050287582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Antibodies that specifically bind to FDF03' [patent_app_type] => utility [patent_app_number] => 11/198819 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30953 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287582.pdf [firstpage_image] =>[orig_patent_app_number] => 11198819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5135616 [patent_doc_number] => 20070077245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'NOTCH mutations leading to increased receptor signaling' [patent_app_type] => utility [patent_app_number] => 11/194913 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 11202 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077245.pdf [firstpage_image] =>[orig_patent_app_number] => 11194913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563700 [patent_doc_number] => 20090136552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Growth factors nsg28, nsg30, and nsg32' [patent_app_type] => utility [patent_app_number] => 11/659016 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 56854 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136552.pdf [firstpage_image] =>[orig_patent_app_number] => 11659016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5784334 [patent_doc_number] => 20060204508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Treatment of autoimmune diseases using an activator for the notch signalling pathway' [patent_app_type] => utility [patent_app_number] => 11/188417 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 65864 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204508.pdf [firstpage_image] =>[orig_patent_app_number] => 11188417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91702 [patent_doc_number] => 07732146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Method for screening an agent that modulates activity of macrophage migration inhibitory factor' [patent_app_type] => utility [patent_app_number] => 11/182241 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 42576 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732146.pdf [firstpage_image] =>[orig_patent_app_number] => 11182241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977899 [patent_doc_number] => 20050287617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Inhibitors of macrophage migration inhibitory factor and methods for identifying the same' [patent_app_type] => utility [patent_app_number] => 11/182360 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 41897 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287617.pdf [firstpage_image] =>[orig_patent_app_number] => 11182360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534061 [patent_doc_number] => 20090233849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Recombinant Alpha-Fetoprotein, Method and Means for Preparation Thereof, Compositions on the Base Thereof and Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/632409 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9633 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233849.pdf [firstpage_image] =>[orig_patent_app_number] => 11632409 [rel_patent_id] =>[rel_patent_doc_number] =>)